Drug Type Mesenchymal stem cell therapy |
Synonyms NV-001 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Novellus LLCStartup |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | IND Application | US | 30 Nov 2022 | |
COVID-19 | IND Application | US | Novellus LLCStartup | 30 Nov 2022 |
Respiratory Distress Syndrome, Adult | IND Application | US | 30 Nov 2022 | |
Respiratory Distress Syndrome, Adult | IND Application | US | Novellus LLCStartup | 30 Nov 2022 |
Respiratory Distress Syndrome, Acute | Preclinical | US | Novellus LLCStartup | 15 Oct 2020 |